- Home
- NKTX vs KNDI Comparison
NKTX vs KNDI Comparison
Compare NKTX & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTX
- KNDI
- Stock Information
- Founded
- NKTX 2015
- KNDI 2002
- Country
- NKTX United States
- KNDI China
- Employees
- NKTX N/A
- KNDI N/A
- Industry
- NKTX Biotechnology: Pharmaceutical Preparations
- KNDI Auto Manufacturing
- Sector
- NKTX Health Care
- KNDI Consumer Discretionary
- Exchange
- NKTX Nasdaq
- KNDI Nasdaq
- Market Cap
- NKTX 123.5M
- KNDI 109.2M
- IPO Year
- NKTX 2020
- KNDI N/A
- Fundamental
- Price
- NKTX $2.30
- KNDI $1.24
- Analyst Decision
- NKTX Strong Buy
- KNDI
- Analyst Count
- NKTX 5
- KNDI 0
- Target Price
- NKTX $13.50
- KNDI N/A
- AVG Volume (30 Days)
- NKTX 1.2M
- KNDI 130.3K
- Earning Date
- NKTX 11-06-2025
- KNDI 11-17-2025
- Dividend Yield
- NKTX N/A
- KNDI N/A
- EPS Growth
- NKTX N/A
- KNDI N/A
- EPS
- NKTX N/A
- KNDI N/A
- Revenue
- NKTX N/A
- KNDI $104,035,613.00
- Revenue This Year
- NKTX N/A
- KNDI N/A
- Revenue Next Year
- NKTX N/A
- KNDI N/A
- P/E Ratio
- NKTX N/A
- KNDI N/A
- Revenue Growth
- NKTX N/A
- KNDI N/A
- 52 Week Low
- NKTX $1.31
- KNDI $0.89
- 52 Week High
- NKTX $4.55
- KNDI $1.81
- Technical
- Relative Strength Index (RSI)
- NKTX 53.68
- KNDI 45.30
- Support Level
- NKTX $2.11
- KNDI $1.20
- Resistance Level
- NKTX $2.74
- KNDI $1.35
- Average True Range (ATR)
- NKTX 0.18
- KNDI 0.06
- MACD
- NKTX 0.03
- KNDI 0.00
- Stochastic Oscillator
- NKTX 39.58
- KNDI 29.41
About NKTX Nkarta Inc.
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
About KNDI Kandi Technologies Group Inc
Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.